Пређи на главни садржај

Истакнути

Unraveling the Mystery: Can Weather-Related Pressure Changes Affect Your Joints?

  Many people with arthritis or other joint conditions claim they can predict changes in the weather based on how their joints feel. While it may sound like folklore, there is some scientific evidence to support the idea that weather-related pressure changes can indeed impact joint health and cause discomfort for some individuals. Let's explore this phenomenon further and uncover the potential link between weather and joint pain. 1. The Barometric Pressure Connection: Barometric pressure, also known as atmospheric pressure, refers to the pressure exerted by the weight of the air molecules in the atmosphere. Changes in barometric pressure occur in response to weather patterns such as changes in temperature, humidity, and altitude. Some researchers believe that fluctuations in barometric pressure can affect the fluid inside joints, causing expansion or contraction of tissues and triggering pain signals in sensitive individuals. 2. Scientific Studies: While anecdotal evidence abound
Постави коментар
Прикажи све

First cannabis drug epilepsy NHS funded

Резултат слика за First cannabis drug

NHS will start prescribing its first cannabis-based medicine for epilepsy in just three weeks after health bosses 'fast-track' funding

  • Epidyolex with clobazam will be given to people with two rare forms of epilepsy 
  • The NHS has negotiated a special price for the £850-a-bottle medication 
  • 2,000 patients with Dravet syndrome or Lennox Gastaut syndrome could benefit
  • Research has suggested the drug can cut seizures by up to 40 per cent 


  • The NHS will start prescribing its first cannabis medicine for epilepsy in less than three weeks' time, it has announced.
    Health bosses have officially confirmed the drug combination Epidyolex with clobazam will be available on prescription from January 6 in England.
    The drug has been hailed as a game-changer for children with severe epilepsy and studies suggest it can cut seizure numbers by up to 40 per cent.
    Some 2,000 patients could be eligible for the medicine, which costs a staggering £850 for a single 100ml bottle, although the NHS will pay a secretive lower price.
    It was tipped for health bosses' approval in November and this has now been finalised and the funding fast-tracked so patients can get it almost right away.
    The announcement makes Epidyolex the third cannabis-based medicine to be approved for NHS prescription, and the first one for epilepsy.  
    This approval was made possible after a lengthy campaign by the parents of epileptic children, such as Charlotte Caldwell and her son Billy, persuaded the Government to legalise cannabis medicines.


    Chief executive of the charity Epilepsy Action, Philip Lee, said he was 'delighted' by the news.  
    'New treatment options for severe epilepsies do not come very often and many families feel they have already been waiting too long to access medicines like Epidyolex,' he said.
    'This announcement brings much-needed hope and could be life-changing for some.'
    Epidyolex and other cannabis-containing drugs were legalised by the Government in November 2018 but were not deemed cost-effective for the NHS. Source: dailymail

Коментари

Постави коментар

Популарни постови